94 related articles for article (PubMed ID: 2904564)
21. Uterine pleomorphic rhabdomyosarcoma in a patient receiving tamoxifen therapy.
Okada DH; Rowland JB; Petrovic LM
Gynecol Oncol; 1999 Dec; 75(3):509-13. PubMed ID: 10600318
[TBL] [Abstract][Full Text] [Related]
22. Myxoid leiomyosarcoma of the uterus in a patient receiving tamoxifen therapy: a case report.
Botsis D; Koliopoulos C; Kondi-Pafitis A; Creatsas G
Int J Gynecol Pathol; 2006 Apr; 25(2):173-5. PubMed ID: 16633068
[TBL] [Abstract][Full Text] [Related]
23. The risk of developing uterine sarcoma after tamoxifen use.
Lavie O; Barnett-Griness O; Narod SA; Rennert G
Int J Gynecol Cancer; 2008; 18(2):352-6. PubMed ID: 18334013
[TBL] [Abstract][Full Text] [Related]
24. [Diarrhea following whole pelvis irradiation in female pelvic cancer (author's transl)].
Sakurai T; Moriya H; Hareyama M; Nishio M
Nihon Igaku Hoshasen Gakkai Zasshi; 1975 Jul; 35(7):536-44. PubMed ID: 1061050
[No Abstract] [Full Text] [Related]
25. Abnormal uterine bleeding as a presentation of metastatic breast disease in a patient with advanced breast cancer on tamoxifen therapy.
Famoriyo A; Sawant S; Banfield PJ
Arch Gynecol Obstet; 2004 Nov; 270(3):192-3. PubMed ID: 14735373
[TBL] [Abstract][Full Text] [Related]
26. Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer.
Hoogendoorn WE; Hollema H; van Boven HH; Bergman E; de Leeuw-Mantel G; Platteel I; Fles R; Nederlof PM; Mourits MJ; van Leeuwen FE;
Breast Cancer Res Treat; 2008 Nov; 112(1):99-108. PubMed ID: 18064567
[TBL] [Abstract][Full Text] [Related]
27. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
[TBL] [Abstract][Full Text] [Related]
28. Endometrial carcinoma in five patients with breast cancer on tamoxifen therapy.
Mathew A; Chabon AB; Kabakow B; Drucker M; Hirschman RJ
N Y State J Med; 1990 Apr; 90(4):207-8. PubMed ID: 1692115
[No Abstract] [Full Text] [Related]
29. Uterine tumor resembling ovarian sex cord tumors in a patient using tamoxifen: report of a case and review of literature.
Oztekin O; Soylu F; Yigit S; Sarica E
Int J Gynecol Cancer; 2006; 16(4):1694-7. PubMed ID: 16884388
[TBL] [Abstract][Full Text] [Related]
30. Tamoxifen for breast cancer prevention: safety warning.
Wooltorton E
CMAJ; 2002 Aug; 167(4):378-9. PubMed ID: 12197698
[No Abstract] [Full Text] [Related]
31. Risk of malignant mixed mullerian tumors after tamoxifen therapy for breast cancer.
Curtis RE; Freedman DM; Sherman ME; Fraumeni JF
J Natl Cancer Inst; 2004 Jan; 96(1):70-4. PubMed ID: 14709741
[TBL] [Abstract][Full Text] [Related]
32. [Tamoxifen and endometrial adenocarcinoma].
Rodier JF; Camus E; Janser JC; Renaud R; Rodier D
Bull Cancer; 1990; 77(12):1207-10. PubMed ID: 2081280
[TBL] [Abstract][Full Text] [Related]
33. [Uterine pathology in women with breast cancer treated with tamoxifen].
Carcangiu ML
Pathologica; 1997 Jun; 89(3):223-33. PubMed ID: 9380417
[No Abstract] [Full Text] [Related]
34. [Can tamoxifen prevent breast cancer?].
Delaloye JF
Rev Med Suisse Romande; 1995 May; 115(5):361-3. PubMed ID: 7770680
[No Abstract] [Full Text] [Related]
35. High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients.
Magriples U; Naftolin F; Schwartz PE; Carcangiu ML
J Clin Oncol; 1993 Mar; 11(3):485-90. PubMed ID: 8383191
[TBL] [Abstract][Full Text] [Related]
36. Torsion of a functional ovarian cyst in a premenopausal patient receiving tamoxifen.
Nasu K; Miyazaki T; Kiyonaga Y; Kawasaki F; Miyakawa I
Gynecol Obstet Invest; 1999; 48(3):200-2. PubMed ID: 10545747
[TBL] [Abstract][Full Text] [Related]
37. Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features.
Barakat RR; Wong G; Curtin JP; Vlamis V; Hoskins WJ
Gynecol Oncol; 1994 Nov; 55(2):164-8. PubMed ID: 7959278
[TBL] [Abstract][Full Text] [Related]
38. [Risk and prognosis of corpus carcinomas after tamoxifen treatment of breast carcinoma].
Engel J; Hölzel D
Strahlenther Onkol; 2001 Jul; 177(7):371. PubMed ID: 11505623
[TBL] [Abstract][Full Text] [Related]
39. Tamoxifen and endometrial cancer.
Jordan VC
Lancet; 1989 Apr; 1(8640):733-4. PubMed ID: 2564550
[No Abstract] [Full Text] [Related]
40. Tamoxifen and endometrial cancer.
Jordan VC
Lancet; 1988 Oct; 2(8618):1019. PubMed ID: 2902449
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
